Ciprofloxacin Injection 100ml Glass Vial

• Customization: Available
• Application: Internal Medicine
• Usage Mode: IV
• Model NO.: 100ml
• Suitable for: Elderly, Children, Adult
• State: Infusion
• Shape: Infusion
• Type: Organic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: H13022479
• GMP: ISO GMP
• Transport Package: 80 Vials/Carton
• Specification: 100ml; : 200mg
• Origin: China
• HS Code: 3004909099

Product Description

CIPROFLOXACIN INJECTION

COMPSSITION:
Ciprofloxacin Injection is supplied as clear almost colorless to faint yellow solution of ciprofloxacin 2 mg/ml in bottle of 100ml.
Each 100ml contains:
Ciprofloxacin BP......200mg
Sodium Chloride BP...…900mg
Water for injection BP…q.s.
DESCRIPTION:
Ciprofloxacin is new fluoroquinolone antimicrobial agent with potent activity against a broad spectrum of gram positive and gram negative bacterial including Psaeruginossa. Enter obacteriaceae and staphylococcus Aureus.
ANTIMICROBIALACTIVITY:
Ciprofloxacin eliminates 99% of bacteria in just 19 minutes. The rapidbactericidal action of Ciprofloxacin is attributed to its umque mode of action. Ciprofloxacin like other fluoroquinolones, blocks bacterial DNA gyrase and disrupts the DNA functions leading to death of bacteria. In addition, Ciprofloxacin damage bacterial cell membrane leading to extrusion of cell contents. Ciprofloxacin is effective against both relicating strains and bacteria in stationary phase. It has significant post-antibiotic effect up to 6 hours and thus prevents regrowth of bacteria. Ciprofloxacin does not disturb normal intestinal or vaginal flora and has no significant effect against anaerobes. Bacterial resistance with Ciprofloxacin is extremely rare. There is no plasmidome diated resistance and it does not show any cross resistance with other antibiotics or antibacterial agents except fluoroquinolones. Ciprofloxacin has an antibacterial spectrum which is wider than the spectrum of ammoglycosides, third generation cephalosporinsand other fluoroqunolones. Ciprofloxacin is active against a wide range of gram-positive and gram-negative pathogens including strams resistant to penicillins, cephalosporins an/or aminoglycosides. Ciprofloxacin's spectrum includes the following organisms.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.